Company intelligence / Profile preview
Thirona Biosciences
San Diego, California, United Statesthironabio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The FDA activated the IND for TBIO-101 after the drug demonstrated a clean pre-clinical safety profile and significant reduction in profibrotic biomarkers of disease[4]
- Therapeutic areas
- OncologyDermatologyRheumatologyImmunology
- Modalities
- Small molecule drugs
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
MannKind Corporation (for FBM5712 development for pulmonary fibrosis)[8]
Beyond the preview
Go deeper on Thirona Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thirona Biosciences.